The Food and Drug Administration just approved the new type of flu vaccine for adults ages 50 and older. It relies on the ...

Compared with standard flu shots, Moderna’s mFlusiva generates stronger, longer-lasting immunity and is more effective at ...

The new mRNA vaccine provides more protection than the standard flu shot.

Previously, the COVID-19 immunizations made by Pfizer and Moderna were the only mRNA vaccines on the market.

Moderna received FDA approval for its new mRNA-based flu shot for older adults after months of regulatory questioning.

The shot, made by Moderna, will be available for this year's upcoming flu season.

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. MRNA technology was thrust ...

The agency's former top vaccine regulator declined to review the Moderna shot, and it's now likely to face pushback from ...

When the first messenger RNA (mRNA) vaccines proved effective during COVID, many experts viewed them as a short-term fix. Five years later, the same technology evolved into one of medicine’s most ...

On August 5, Health Secretary Robert F. Kennedy Jr. announced that the Department of Health and Human Services would terminate almost $500 million in mRNA vaccine development grants and contracts, ...

Add Yahoo as a preferred source to see more of our stories on Google. But now, the U.S. federal government is slashing its investments in mRNA vaccines — a move that will immediately impact 22 ...